Comversation with with Pierre Pellier: Enhancing Detection of Patients Eligible for Clinical Trials

An Empowered Patient Podcast at Medical and Pharma Insider hosted by Karen Jagoda


Pierre Pellier, CEO of CTMA's objective is to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.

Using CTMA's CT-Scout platform on a mobile device, doctors are prompted to ask, during a consultation, a few selected questions to determine whether a particular patient might be eligible for any of the numerous studies running at their site.


Removing the need to remember major inclusion and exclusion criteria encourages doctors and investigators to broaden the search and increase recruitment.

Listen to Podcast

Podcast Transcript